QFMHK
DNA icon

Q Fund Management (Hong Kong)’s Ginkgo Bioworks DNA Stock Holding History

Q Fund Management (Hong Kong)’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$505K Buy
+39,330
New +$320K 0.49% 20

Other funds holding DNA

BSWM
Boston Standard Wealth Management Winchester, Massachusetts $696M AUM 8.98% 1-Year Est. Return
TWM
TriaGen Wealth Management Calabasas, California $413M AUM 35.91% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
EP
Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return
ATC
Adirondack Trust Company Saratoga Springs, New York $320M AUM 23.25% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return

Q Fund Management (Hong Kong)'s DNA Position: Q3 2026 in Review

Q Fund Management (Hong Kong) opened a new position in Ginkgo Bioworks (DNA) in Q3 2026: 39,330 shares worth $505K. The stake represents 0.49% of the portfolio and ranks #20 among its holdings.

9 funds tracked by Wall St. Rank hold DNA as of Q3 2026.

  • Q Fund Management (Hong Kong) held 39,330 shares of Ginkgo Bioworks worth $505K as of Q3 2026.
  • Ginkgo Bioworks was a new Q Fund Management (Hong Kong) position in Q3 2026.
  • Ginkgo Bioworks made up 0.49% of Q Fund Management (Hong Kong)'s portfolio in Q3 2026, its #20 holding.
  • 9 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q3 2026.

Based on Q Fund Management (Hong Kong)'s 13F filing for Q3 2026, filed 14 Oct 2026.